Format

Send to

Choose Destination
See comment in PubMed Commons below
Aliment Pharmacol Ther. 2002 Mar;16 Suppl 1:40-6.

Review article: Helicobacter pylori and gastric adenocarcinoma.

Author information

  • 1University of Texas Southwestern Medical Center at Dallas, Texas, USA. wpetersonmd@cs.com

Abstract

Gastric adenocarcinoma is still the second most common cause of death from cancer, even though it is on the decline in developed countries. Although H. pylori gastritis appears to be a necessary antecedent to the development of gastric adenocarcinoma, it is not a sufficient factor in and of itself. Other required factors for the progression of this disease are poorly understood. Patients with antral predominant gastritis seem protected from the disease, while patients with pangastritis are predisposed to both diffuse- and intestinal-type adenocarcinoma. Development of a vaccine against H. pylori might yield promising results in decreasing the incidence of gastric adenocarcinoma.

PMID:
11849127
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk